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ABSTRACT
Mastitis is an inflammation of the mammary gland that costs the United States dairy
industry between $1.7 and $2 billion annually [9]. Approximately 97% of mastitis
infections are caused by bacteria, which can be treated with antibiotics [2]. However,
mastitis infections can be caused by the alga, Prototheca. Specifically, it is P. zopfii
(genotype 2) and P. blaschkeae that have been found in cows with mastitis [7]. There are
currently no approved treatments for protothecal mastitis. The following experiments a
tested the effects of grapefruit seed extract (GFSE) on P. zopfii (genotype 2) using
spectrophotometry and plating techniques. GFSE was chosen because previous research
has shown it has antimicrobial properties, it is water soluble, inexpensive, and has the
potential to be a legal treatment. Prototheca isolation medium (PIM) broth was inoculated
with P. zopfii colonies to 47% transmittance (T). Serial dilutions of GFSE were made 1:1
with distilled water (DW) starting at 4,000ug/mL down to 125ug/mL. These dilutions
were mixed 1:1 with 47% PIM and incubated for 72 hours. Absorbance readings were
taken at 0, 24, 48, and 72 hours, and the samples plated on blood agar to evaluate the
sterility of the samples.It was found that not even the highest concentration of GFSE was
effective at inhibiting the P. zopfii (G2) colonies. However, this study does not preclude
that GFSE may be effective against P. zopfii growth under different conditions.
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INTRODUCTION
Mastitis is an inflammation of the mammary gland that results in scarring of the
mammary tissue, reduced milk production, and sometimes systemic illness [1]. Mastitis is
seen most commonly in dairy cattle, and can be caused by physical trauma (about 1% of
cases), or by an infection [1]. The organisms that cause this infection usually enter the
udder through the teat canal [2]. The organisms kill the milk-secreting epithelial cells
within the udder, which then slough off and are replaced with scar or connective tissue,
thus leading to reduced milk production. Mastitis is separated in to four categories:
peracute, acute, subacute, and subclinical [1]. Peracute mastitis presents as a swollen, hot,
and red udder followed by systemic illness that includes fever, depression, shivering,
weight loss, and sometimes death. Acute mastitis also includes severe udder
inflammation, but less severe or no systemic signs. Subacute mastitis presents as a mildly
infected udder, with no systemic illness. The least severe, subclinical, is when the
mammary gland and cow show no outward signs, but when the milk is cultured and a
somatic cell count (SCC) performed, the milk shows the presence of infectious organisms
and an increase in SCC. Mastitis infections can lower production rates on dairy farms by
as much as 15-20% per infected animal [2], and some farms can have infection rates of
up to 70% of the cattle.
Decreased milk production, increased cost of treatments, and increased culling
due to mastitis result in a dramatic decrease of profit for farmers. The biggest economic
loss to farmers is from reduction in total milk produced. Consider a 500-cow herd that is
averaging 50 lbs. milk/cow/day for 365 days per year. If they experience a 20% milk loss
at a price of $16/100 lbs. of milk, in one year the farm would lose $58,400 due to mastitis
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[2]. Mastitis incidence rates on well-managed farms are generally less than 20%, but
some farms may have as many as 70% of the cattle with mastitis in at least one quarter of
the udder at any one time.
The largest portions of mastitis infections, approximately 95%, are caused by
bacteria such as Streptococcus agalactiae, Staphylococcus aureus, Streptococcus
dysgalactiae, Streptococcus uberis, Escherichia coli, and coagulase-negative
Staphylococci [2]. Treatment options for bacterial mastitis infections include intramammary infusions and systemic antibiotic treatments. Antibiotics that are approved for
lactating dairy cows include amoxicillin, ampicillin, ceftiofur, cepharin, cloxacillin,
erythromycin, hetacillin, novobiocin, penicillin G and pirlimycin[15]. While these
antibiotics are being used and for usually four to five days afterwards [15], the milk
cannot be sold for human consumption. If caught selling contaminated milk the farm is
rendered a severe financial penalty and must pay for the entire truck of contaminated
milk. If a farm is found to violate residue laws three times within a year, the milker’s
permit is revoked [16]. The top reasons cited for residue violation are that the milker was
too rushed, there was a new milker working that day, the treated cow just rejoined the
milking herd, or there was a failure to mark the treated cows [15]. The costs of treatment,
the money lost from milk withholding, and any accidental fines make treating bacterial
mastitis still costly to the farmer.
The other 5% of mastitis infections are caused by other organisms, including
Prototheca. Prototheca is a colorless alga that persists in wet environments containing
decaying organic matter such as feces or plants [10]. There are five different species of
Prototheca, but only P. zopfii (gentoype 2) and P. blaschkeae have been found within the
2

milk secretions of dairy cows with mastitis [7]. There is currently no treatment for
protothecal mastitis, and due to its negative effect on milk quality and production, culling
is usually suggested for infected cows [10]. Culling results in decreases in profits for
dairy farmers, due to the cost of replacing the cow.
While the number of Prototheca-caused mastitis cases is not extremely high [10],
the alga is resistant to current mastitis treatments and can be resistant to current
pasteurization methods [12]. This study tests whether a naturally occurring fungicide can
effectively kill common strains of Prototheca, in vitro. If so, steps could be made towards
creating a viable treatment of protothecal mastitis, and thus Maine dairy farmers may
eventually benefit by using an inexpensive treatment to avoid culling infected cattle.
Studies of many different algaecides, including amphotericin B, nystatin,
polymyxin B, gentamicin and neomycin, have been conducted on Prototheca [12]. These
algaecides were all tested in vitro and most were successful at inhibiting the Prototheca
species to some degree. However, farmers cannot legally use these algaecides in dairy
cattle. Farmers do not wish to lose profit by throwing away milk, or risk receiving a large
fine for sending milk containing antibiotics or other chemicals into the processing plant.
Instead of treating a cow with protothecal mastitis, they would either milk the cow last to
avoid spreading the infection to rest of the herd via milking equipment, or they would
cull the infected animal. Use of good hygiene and culling infected animals is the best
route to avoid the spread of infection. However, culling the infected animals can be costly
to the farmer. Therefore, finding an inexpensive way to treat a prototheca infection that
allows the milk to be sold soon after treatment would be the best way to return profits to
Maine dairy farmers.
3

Effective methods of treating Prototheca should be based on the principles of
action of antimicrobials known to be effective against related organisms. Prototheca is
closely related to yeast, which is a fungus containing ergosterol in its cell membrane.
Ergosterol is a sterol similar in composition to cholesterol [4], providing support to the
cell membrane. Compounds, such as amphotericin B [5], kill yeast by attaching to
ergosterol and creating ion channels, a process called channel-mediated membrane
permeabilization [5]. These channels allow ions to leak out of the cell, causing death of
the cell via osmosis. The cell membrane of Prototheca is 4% ergosterol [11], suggesting
that agents that kill yeast via ergosterol binding may also kill Prototheca species.
A “natural” remedy suggested to treat yeast infections in humans is grapefruit
seed extract (GFSE) [3]. Grapefruit seed extract (GFSE) has antibacterial properties when
diluted as much as 1:512 with only 15 minutes contact time [6] against both gram
negative and gram positive organisms. It has also been suggested to be effective against
770 different types of bacteria and 93 different fungi [8]. The mechanism for GFSE
activity against yeast is unknown, and some suggest it is not the GFSE that is effective
against yeast, but possibly the preservative in commercially prepared GFSE [13].
Therefore, obtaining pure GFSE for experimentation purposes is ideal. The GFSE used in
this experiment was purchased online, and while the package stated it was “Free of:
sugar, soy, dairy, yeast, gluten, corn, and additives” there is no guarantee from the
company that the GFSE is free of any chemicals from the processing.
Given that GFSE has been reported to be antifungal, it may be effective against
Prototheca growth. Ideally, any anti-protothecal mastitis treatment would be water
soluble, which would allow it to spread throughout the mammary system after an
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intramammary infusion. GFSE is at least slightly water soluble [6], and relatively
inexpensive, making it a good candidate to test in the search for an anti-protothecal
treatment.
If GFSE is effective against P. zopfii growth during an in vitro trial, perhaps
future trials can show positive in vivo effects. Ultimately, one would have to ensure that
milk produced by a cow receiving GFSE treatment still follows the guidelines of the
Pasteurized Milk Ordinance (PMO) set forth by the United States Public Health Service
(USPHS).The ultimate goal of a practical Prototheca treatment is to effectively inhibit
Prototheca growth, to have no impact on the milk quality, and to be inexpensive.
The objective was to test the efficacy of GFSE to prevent the growth of P.zopfii,
in vitro. Our hypothesis was that GFSE will successfully inhibit P.zopfii (G2) growth
because it appears to be effective against yeast, a close relative to Prototheca.
MATERIALS AND METHODS
Experiment 1
The first step to the experiment was determining what concentration of GFSE
would dissolve fully in water. We could then determine the starting point for the serial
dilutions of GFSE treatments. Using a graduated cylinder, we measured out 100mL of
water into a beaker. The GFSE powder used was purchased online from PureBulk, Inc.
(Roseburg, Oregon). The lab analysis of the GFSE can be found in Appendix 1. We
started by adding 1 gram of GFSE, and stirred well with a glass rod. We then centrifuged
the solution for 5 minutes at 2500rpm. We found that a pellet formed at the bottom, and
thus the GFSE did not fully dissolve in the water. We repeated the process with less
GFSE until we found that we could dissolve 0.4grams of GFSE in the 100mL of water
5

without pellet formation. Thus, we decided that we should start with a stock 4000ug/mL
GFSE solution for the serial dilutions.

Experiment 2
Stock GFSE dilutions of 4000ug/mL, 2000ug/mL, 1000ug/mL, 500 ug/mL,
250ug/mL and 125ug/mL were prepared using 1:1 serial dilutions in distilled water
(DW). We started with 50mL of DW and added 0.2grams of GFSE, yielding a stock
solution of 4,000ug/mL. We used a heating plate and a glass stirring rod to help dissolve
the GFSE fully. The GFSE was heated to boiling temperature, or around 100oF. From this
beaker we measured 25mL of the 4,000ug/mL solution into a graduated cylinder, and
poured it into the next container. We added 25mL of DW, giving a new 2,000ug/mL
solution. The container was inverted and shaken to ensure proper mixing. This dilution
processed continued until we had 125ug/mL. The GFSE dilutions were then autoclaved
to ensure sterility.
A P. zopfii (genotype 2) sample was obtained from the American Type Culture
Collection (ATCC). The isolate was stored on cryobeads at -80oC at The University of
Maine. The P. zopfii was cultured on a Sabouraud dextrose agar (SDA) plate for 48hours
at 28oC. A colony was examined under a microscope using a wet-mount to visually
conclude that P. zopfii cultures were indeed the organisms growing on the plate. If the
organisms appeared colorless, spherical, and having multiple endospores like those seen
in Figure 1, we concluded they were P. zopfii. After confirming we had P. zopfii
colonies, a single colony was picked and streaked onto another SDA plate for 96 hours at
28oC.
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Fig.1. P. zopfii colonies cultured and photographed in the University of Maine Animal Health
Lab in Hitchner Hall at the University of Maine.

Fig.2. Labeling of the glass tubes during the experiment. Tubes were covered in aluminum foil
and autoclaved to ensure sterility. There were two trials of treatments performed, labeled
Treatments 1 & 2. The PIM 47% and PIM 47%+Distilled Water tubes were positive controls
(contained Prototheca). The PIM ONLY, GFSE ONLY, GFSE+PIM ONLY, and Distilled Water
tubes were all negative controls (did not contain Prototheca).

Autoclaved tubes were set up in racks and labeled according to Figure 2 (above).
We had four negative controls (Pa-Pf, G1-G6, GP1-GP6, and the 6 DW tubes). There
were 6mLs of autoclaved Prototheca Isolation Media (PIM) broth pipetted into each tube
7

Pa-Pf (36mLs total). The PIM broth was created for another experiment in 2012, and had
been refrigerated since. The ingredient list can be found in Appendix 2. We expected the
PIM ONLY tubes to remain at 0 absorbance after incubation when blanked with PIM,
indicating no colony growth and therefore that the PIM broth was sterile. For the next
negative control, there were 3mLs of each GFSE dilution pipetted into tubes G1-G6
(18mLs total). These also served as negative controls, to ensure the sterility of the GFSE
concentrations. For the third negative control, there were 3mLs each of GFSE dilution
and 3mLs of autoclaved PIM broth pipetted into tubes GP1-6. These also serve as blanks
in the spectrophotometer for the treatment tubes (A1A2-F1F2), because with the
exception of P. zopfii colonies, the treatment tubes are the same as these negative
controls. In the final negative control, 3mLs of autoclaved DW were pipetted into each
DW tube (18mLs total), and used as a negative control to show the DW used throughout
the experiment was sterile.
We also used 2 positive controls for this experiment. There were6mLs of PIM
broth e pipetted in to tubes Ia-If. Using sterile loops, the PIM broth was inoculated with
P. zopfii from the SDA plate. Using a PIM broth blank, the %Transmittance (%T) levels
were read using a Bausch & Lomb Spectronic 20 spectrophotometer. All readings for
this experiment were done at 570nm, and every tube that entered the spectrophotometer
was wiped clean with a KimWipe® to ensure there were no contaminants on the outside
of the tube that may affect the readings. The tubes were stirred with the loop, then
vortexed thoroughly using a Fisher Scientific Standard Vortex Mixer at speed 6 for
approximately 30seconds-1minute. The goal was to create a solution of roughly 47% T.
The reason behind choosing 47% T was based on previous work done in the University
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of Maine Animal Health Lab (UMAHL). The research showed that 47% T is equivalent
to approximately 1x106 colony forming units (CFUs), which would have been useful if
we decided to do any plate counts. These 47% PIM tubes arethe positive controls, to
ensure that the P. zopfii will grow in PIM broth after incubation.
The other positive control was tubes X1-X6, which contained half 47% PIM broth
and half DW. We needed this second positive control for two reasons. The first was to
show that the broth and water combination used in the treatments could indeed grow P.
zopfii. We suspect the P. zopfii will still grow in this diluted PIM broth solution because
the P. zopfii is an alga with a thick cell wall, and thus will not be susceptible to such a
change in osmolarity. The second reason for this positive control is it will provide
appropriate absorbance readings to compare the treatments tubes to (which are half 47%
Prototheca and half DW+GFSE), because we are unsure whether the P. zopfii would
continue to proliferate well in a more hypotonic solution than the PIM broth.
PIM broth (7mL) was then pipetted into six tubes (not pictured in Figure 1).
Using a sterile loop, the PIM broth was inoculated with P. zopfii. Using a PIM blank, the
T levels were read. All six tubes had exactly 47% T, or 0.33 absorbance (A). The first
tube of 7mL was vortexed and 3mL were pipetted into treatment tube A1, and 3mL more
into tube A2. This was continued with all six tubes until all treatment tubes (A1A2-F1F2)
contained 3mL of 47%T PIM. Then, 3mL of each corresponding GFSE dilution was
pipetted into the treatment tubes and then vortexed thoroughly. The absorbance levels
were read, using the corresponding GFSE+PIM control tubes (GP1-GP6) as blanks in the
spectrophotometer.
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All tubes were incubated at 28oC for 24 hours. The tubes were then vortexed and
absorbance levels were read and recorded for all treatment tubes (A1A2-F1F2), as well as
the 47% PIM controls (Ia-If), and the 47% PIM + DW (X1-X6). The samples then
continued to incubate and absorbance readings were read and recording in the same
fashion at 48 and 72 hours.
At 72 hours the GFSE+PIM dilution blanks (GP1-GP6), one of each treatment
tube (A1-D1,E2,F1), and three of the PIM47% controls (Ia-Ic) were plated on blood agar
plates, as diagrammed in Figure 2. We used 1uL loops to streak each 1/3 of the plates.
These plates were then incubated at 34oC, and observed for colony forming units (CFU)
at 24 and 48 hours. We expected to see no growth on the negative controls (GP1-GP6),
solely P. zopfii growth on the positive controls (Ia-Ic), and if the GFSE had effectively
killed the P. zopfii colonies, and no growth on the treatments (A1-D1, E2, F1) would
indicate the GFSE had effectively killed the P. zopfii. At 72 hours we used wet-mounts
under a microscope to observe any colony growth.

Fig. 3. This is a diagram of the blood agar plates. We used sterile 1uL loops to streak each 1/3 of
the plates. The plates were observed at 24, 48, and 72 hours for abnormal colony growth, which
would indicate the solutions harbored organisms other than P. zopfii. At 72 hours any abnormal
colonies were observed using a wet-mount under a microscope, and the assumed P. zopfii
colonies from A1-E2, F1 and Ia-Ic were also checked under the microscope to ensure they were
in fact P. zopfii colonies.
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Experiment 3
This experiment was performed using the exact same procedures as Experiment 2,
except the GFSE solutions were not autoclaved. Subjecting the GFSE to the extreme
temperatures in the autoclave may have altered the components in the GFSE, therefore
we used filtration to sterilize the GFSE rather than autoclaving it. The same serial
dilutions of GFSE were made in DW as in Experiment 2. The solutions were then run
through Corning Incorporated 0.2um sterile syringe filters into sterile tubes. A single P.
zopfii colony from the previously used cultures was streaked onto a fresh SDA plate and
incubated for 48hours at 28oC.
Once again, 2 sets of 6 sterile treatment tubes were set up in a rack (A3A4-F3F4).
We created 6 more tubes with 7mL of 47% PIM broth from the colonies on the new SDA
plate. We used the inoculating and spectrophotometry techniques from Experiment 2 to
create a prototheca concentration of 47% T. From these 6 tubes, we pipetted 3mL of
47% PIM into each of the 12 treatment tubes. We then pipetted 3mL of each filtered
GFSE dilution into corresponding tubes. The tubes were then vortexed thoroughly and
incubated for 72 hours at 28oC.
As was done in Experiment 2, we then created individual blanks for the treatment
tubes. We set up 6 tubes for blanks (GP1-GP6). We pipetted 3mL of sterilized PIM broth
into them. Next we pipetted 3mL of the sterilized GFSE dilution into the blank tubes. We
used these blanks for each corresponding GFSE treatment. Each tube placed in the
spectrophotometer was wiped clean with a KimWipe®, and read at 570nm. We recorded
the absorbance readings for the treatments using these blanks.
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We also used the same positive and negative controls for this experiment as in
Experiment 2. The positive controls to ensure sterility were once again 6 tubes of 6mLs
of 47% PIM broth (Ia-If), and 6 tubes of 3mLs of 47%PIM : 3mL of DW (X1-X6). The
negative controls were 6 tubes of 6mLs of sterilized PIM broth (Pa-Pf), and the 6 tubes of
3mL of GFSE dilutions and 3mL of PIM broth (the blanks for the treatments).All
samples were incubated at 28oC for 72 hours, and both and absorbance readings were
done at 24 hour intervals.
At 72 hours the GFSE serial dilutions (4,000ug/mL – 125ug/mL), one of each
treatment tube (A3, B4, C3, D4, E3, F4), and three of the PIM47% controls (Ia-Ic) were
plated on blood agar plates, as diagrammed in Figure 4. We used 1uL loops to streak each
1/3 of the plates. These plates were then incubated at 34oC, and observed for colony
forming units (CFU) at 24 and 48 hours. We expected to see no growth on the negative
controls (GP1-GP6), solely P. zopfii growth on the positive controls (Ia-Ic), and if the
GFSE had effectively killed the P. zopfii colonies, there would also be no growth on the
treatments (A3B4, etc). At 72 hours we used wet-mounts under a microscope to observe
any colony growth.
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Fig. 4. This is a diagram of the blood agar plates. We used sterile 1uL loops to streak each 1/3 of
the plates. The plates were observed at 24, 48, and 72 hours for abnormal colony growth, which
would indicate the solutions harbored organisms other than P. zopfii. At 72 hours any abnormal
colonies were observed using a wet-mount under a microscope, and the assumed P. zopfii
colonies from A1-E2, F1 and Ia-Ic were also checked under the microscope to ensure they were
in fact P. zopfii colonies.

RESULTS
Experiment 2
Figure 5 shows that the absorbance of the first positive control, the 47% PIM,
continued to increase linearly over the course of incubation.
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Fig. 5. The absorbance of the positive control, 47% PIM, continued to increase over the 72 hours
of incubation. Only the average of the six controls (Pa-Pf) has been graphed, and a linear best-fit
line was applied.

The other positive control used in this experiment was 47% PIM + DW (X1-X6)
in a 1:1 ratio. Similar to the previous positive control, only the average of the absorbance
readings was graphed. As seen in Figure 6, the absorbance readings increased in a linear
fashion, with an R2 value of 0.999 and a slope of 0.00224 A/hr.
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Absorbance of 47% PIM + DW
Absorbance at 570nm

0.35
0.3
0.25
0.2

y = 0.00224x + 0.14950
R² = 0.99965

0.15

Average of X1-X6
0.1
0.05
0
0

24

48

72

96

Hours
Fig. 6. The average absorbance readings for the positive controls (X1-X6) increased in a linear
fashion over the 72 hours of incubation. The linear best-fit line has an R2 value of 0.999 and an
equation of y=0.00224x + 0.1495. The slope of these absorbance readings will be compared to
the slopes of the treatment tubes (A1A2-F1F2).

As seen in Figure 7, the absorbance of the GFSE treatments increased during
incubation. The absorbances of the two trials of each treatment concentration were
averaged before being graphed. Linear best-fit lines using Microsoft Excel were applied
to each GFSE treatment absorbance reading (not pictured). The 47% positive control was
also graphed. The slope values of each GFSE treatment were compared to the slope
values of the 47% PIM + DW positive control in Table 1.
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Absorbance of GFSE Treatments and Positive
Control

0.35

Absorbance at 570 nm

0.3

2000ug/mL
0.25

1000ug/mL
500ug/mL

0.2

250ug/mL
0.15

125ug/mL
62.5ug/mL

0.1

Positive Control

0.05

Linear (Positive Control)

0
0

24

48

72

Hours
Fig. 7. The absorbance readings for two trials of each treatment were averaged and then graphed.
The GFSE treatment absorbances increased linearly during incubation. The positive control is
graphed for comparison, and the best-fit linear line is shown to emphasize the general slope. The
slopes of the best-fit lines are compared to that of the positive control in Table 1.
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Table 1. Comparing the slopes of the absorbance readings of the treatments to the slopes of the
absorbance readings of the 47% PIM + DW controls.
47% PIM +
Slope
#STD Away Treatments
Slope
# STD Away Average
DW Controls
(A/hr)
from Mean
(A/hr)
from Mean
X1

0.00208

-1.468

2000ug/mL

0.00200

-0.106

X2

0.00221

-0.266

2000ug/mL

0.00238

1.337

X3

0.00238

1.337

1000ug/mL

0.00192

-3.071

X4

0.00233

0.936

1000ug/mL

0.00208

-1.468

X5

0.00221

-0.266

500ug/mL

0.00179

-4.272

X6

0.00221

-0.266

500ug/mL

0.00221

-0.266

Average

0.002236

Standard
Deviation

0.000104

250ug/mL
250ug/mL

0.00196
0.00250

-2.670
2.538

125ug/mL

0.00217

-0.667

125 ug/mL

0.00233

0.936

62.5ug/mL
62.5 ug/mL

0.00233
0.00233

0.936
0.936

0.615

-2.269

-2.269

-0.066

0.135

0.935897

The slope values for 47%PIM + DW treatments were calculated using Excel. The average and
standard deviation were found. The slopes of the treatments were then calculated in a similar
manner, and compared to the standard deviation of the control. The numbers of standard
deviations from the mean of the two similar treatments were then averaged.

The % T and A readings of the negative control, PIM ONLY broth, (Pa-Pf)
showed no change after incubation.
The blood agar plate with Ia-Ic showed growth in all three thirds. All the colonies
were uniform (small, greyish-clear colonies), and upon examination under a microscope
using a wet mount, they appeared to be P. zopfii as they appeared similar to those shown
in Figure 1. There was a single yellowish colony in Ic, that was considered to be a
contaminant from the plating process, as it was not widespread throughout the plate.
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The blood agar plates with GP1-GP6 showed no growth, except another small
yellowish colony in GP2. This also was considered to be a contaminant from the plating
process as well, as there was just a single colony.
The final blood agar plates, containing A1-D1, E2, and F1, showed what appeared
to be solely P. zopfii growth (small, greyish clear colonies). Upon examination under the
microscope using a wet-mount they appeared to be P. zopfii.

Experiment 3
Comparable to Experiment 2, the absorbance readings of the positive control,
47% PIM, increased linearly over time in Figure 8. The exponential trend line did not
seem to fit as accurately as in Experiment 2 (see Figure 4), as indicated by the R2 value.

Absorbance of 47% PIM
0.7

Absorbance at 570nm

0.6
0.5

y = 0.0042x + 0.361
R² = 0.9398

0.4
0.3

Average of Ia-If

0.2
0.1
0
0

20

40

60

80

Hours

Fig. 8. The absorbance for the positive controls in Experiment 3 also continued to increase over
time. The linear trend-line did not fit as well, as indicated by the R2 value, and the data suggests
the P. zopfii colonies grew extremely fast during the initial 24 hour incubation period.
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Figure 9 shows the absorbance readings of the 47% PIM + DW increasing
linearly, as in Experiment 2. Again, a best-fit linear line was applied, and the slope value
was compared to that of the GFSE treatments.

Absorbance of 47% PIM + DW
0.45

Absorbance at 570nm

0.4
0.35
0.3
0.25

y = 0.0031x + 0.1784
R² = 0.9608

0.2

Average of X1-X6

0.15
0.1
0.05
0
0

20

40

Hours

60

80

Fig. 9. The absorbance readings for 47% PIM + DW increased in a linear fashion during
incubation. This slope is used in comparison with the treatments from Experiment 3.

Figure 10 contains the absorbance readings from the GFSE treatments. The slopes
of the linear best-fit lines from Figure 10 are compared to the positive control slope (also
pictured). These comparisons are seen in Table 2.
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Absorbance for GFSE Treatments

0.5

Absorbance at 570nm

0.45

2,000ug/mL

0.4
1,000 ug/mL

0.35

500 ug/mL

0.3
y = 0.0031x + 0.1784
R² = 0.9608

0.25

250 ug/mL

0.2

125 ug/mL

0.15

62.5 ug/mL

0.1

Positive Control

0.05
0
0

24

48

Hours

72

96

Fig. 10. The absorbance readings of the GFSE treatments increase linearly over the incubation
period. The slopes of the best-fit lines are compared to the slope of the best-fit line of the positive
control, 47% PIM + DW. This is included on the graph, and a best-fit line has been applied.
Table 2.

47% PIM
+ DW
Controls
X1
X2
X3
X4
X5

Slope
(A/hr)

#STD
Away
from
Mean

0.00317

-1.693

0.00366

0.14

0.00356

-0.2419

0.004

1.362

0.00363

-0.01273

X6

0.00375

Average

0.00363

Standard
0.000273
Deviation

0.4456

Treatments

Slope
(A/hr)

# STD
Away
from
Mean

2000ug/mL
2000ug/mL
1000ug/mL
1000ug/mL
500ug/mL
500ug/mL
250ug/mL
250ug/mL

0.003583

0.003458

-0.1722
-0.1722
-1.0879
-0.4762
1.65934
-0.0183
-0.4762
-0.63

125ug/mL

0.0035

-0.4762

0.003583
0.003333
0.0035
0.004083
0.003625
0.0035

125 ug/mL 0.003917
62.5ug/mL 0.003667
62.5 ug/mL 0.003792

1.05128
0.13553
0.59341

Average

-0.1722
-0.7821
0.82051
-0.5531
0.28755
0.36447

The slope values for 47%PIM + DW treatments were calculated using Excel. The average and
standard deviation were found. The slopes of the treatments were then calculated in a similar
manner, and compared to the standard deviation of the control. The numbers of standard
deviations from the mean of the two similar treatments were then averaged.
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The PIM ONLY tubes from Experiment 3 showed no change in absorbance, and
thus were considered sterile.
The blood agar plate with Ia-Ic showed what appeared to be a lawn of P. zopfii
colonies after 48 hours of incubation. There were no other colonies other than the small,
white greyish ones associated with P. zopfii. The blood agar plates with the standard
stock solution showed no colony growth. The final blood agar plates, containing the
treatments (A3B4, etc) also showed a lawn of P. zopfii-like growth, and no other
colonies.

DISCUSSION AND CONCLUSION
Experiment 2
Figure 5 and theblood agar plate results illustrate that PIM broth facilitates the
growth of P. zopfii. The increasing absorbance suggests the P. zopfii continued to
increase in turbidity, thus increasing in numbers after incubation. Also, once Ia-Ic were
plated on blood agar, all the colonies appeared to be P. zopfii colonies, and the
absorbance readings were not due to the growth of other colonies. The other positive
control, the 47% PIM + DW also showed an increase in absorbance levels after
incubation, as shown in Figure 6. This indicates the P. zopfii was able to proliferate in a
more hypotonic solution than just PIM broth. When the slopes of the 47%T PIM and
47%T PIM + DW are compared, there is very little difference, although it appears the
additional water may have slowed the P. zopfii growth slightly. Thus, we can conclude
the P. zopfii was able to proliferate when the 47% PIM was combined in a 1:1 ratio with
DW, and we now have absorbance readings to compare the GFSE treatments to.
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The PIM ONLY tubes, one of the negative controls, showed no change in
absorbance, indicating sterility. Another negative control, the GFSE+PIM broth (GP1GP6), once plated on blood agar, proved to be sterile (except for the single contaminant
assumed to be from plating). The blood agar plates were used instead of SDA or PIM
plates because blood agar plates facilitate the growth of most all organisms. Therefore,
they would be a better indicator of contamination over SDA or PIM plates that only
facilitate growth of certain organisms. This means the GFSE treatments were all sterile,
and that GP1-GP6 were appropriate blanks for the GFSE treatment tubes (A1A2-F1F2).
We can also infer the GFSE negative controls (G1-G6) were sterile (since they came
from the same stock GFSE solutions as the GP1-GP6 tubes), so we did not plate them on
blood agar.
Figure 7 indicates that P. zopfii continued to proliferate in PIM broth regardless of
the presence of GFSE. When compared to the positive control, it appears the slope of the
GFSE treatments is similar to that of the control, even though the y-intercepts are quite
different. We believe this was due to improper mixing of the 47% PIM before it was
pipetted into the treatment tubes. Also, it can be inferred from the plating of the GFSE
treatment tubes that the organisms that were continuing to grow were indeed P. zopfii,
and not some contaminant. Table 1 allows us to infer that the presence of the GFSE, in
any of the tested concentrations, had no effect on the P. zopfii growth.
Table 1 shows the calculated best-fit slopes of the positive control, 47% PIM
+DW. The average of these slopes was found, as well as the standard deviation. The
slopes of the treatment tubes were also found, and compared to the average slope of the
controls by using the standard deviations. Typically, anything within 2 standard
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deviations is considered within the “normal” limits. The slope of the highest
concentration of GFSE has an average # of standard deviations of less than 1from the
mean, meaning it is not different from that of the control. This means the growth rate of
the P. zopfii subjected to the highest level of GFSE is not different from the growth rate
of the P. zopfii control. The 1,000ug/mL and 500ug/mL treatments have an average # of
standard deviations from the mean of over 2. This would make us assume the growth rate
of the P. zopfii in these treatments is different from that of the control. However, because
the higher concentration did not seem to inhibit P. zopfii growth, it seems unusual for a
lower concentration to slow the growth rate. We believe these results are due to the fact
we only have 2 trials of the treatments, and it is likely that with more trials the average
slope would be within 2 standard deviations from the slope of the controls. The lower
concentration treatments are all also within 1 standard deviation of the control,
suggesting the growth rate of the P. zopfii in the treatments are similar to the growth rate
of the P. zopfii the control. However, with our limited number of trials we do not have
enough data to accurately perform a statistical analysis.
Experiment 3
The difference between Experiment 2 and Experiment 3 was that the GFSE
concentrations were sterilized with a syringe filter instead of being autoclaved. Figure 7
and the blood agar plates illustrate the PIM broth supported the growth of the P. zopfii.
The absorbance readings increased linearly during incubation, and once Ia-Ic were plated
on blood agar, it was shown the colonies were all P. zopfii. Theother positive control, the
47% PIM + DW also showed increasing absorbance levels after incubation, as shown in
Figure 8. Thus, we can conclude the P. zopfii was able to proliferate when the 47% PIM
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was combined in a 1:1 ratio with DW, and we had absorbance readings to compare the
GFSE treatments to.
The PIM ONLY tubes, one of the negative controls, did not show any change in
absorbance after incubation. This means the PIM media was sterile, and the filtration did
indeed sterilize the GFSE solutions. Once we plated the serial dilutions of GFSE on
blood agar, they showed no culture growth. This means the filters also worked to sterilize
the GFSE treatments.
The information in Figure 10 confirmed P. zopfii continued to proliferate in the
PIM broth regardless of the presence of GFSE because the absorbance readings continued
to increase after incubation. Also, it can be inferred from the plating of the GFSE
treatment tubes that the organisms that were continuing to grow were indeed P. zopfii,
and not some contaminant. The absorbance rates were increasing in a nearly identical
fashion for all treatments, thus suggesting that the presence of the GFSE did not affect the
growth rate. Table 2 allows us to infer that the presence of the GFSE, in any of the tested
concentrations, had no effect on the P. zopfii growth.
Table 2 shows the calculated best-fit slopes of the positive control, 47% PIM
+DW. The average of these slopes was found, as well as the standard deviation. The
slopes of the treatment tubes were also found, and compared to the average slope of the
controls by using the standard deviations. Once again, anything within 2 standard
deviations is considered within the “normal” limits. The highest concentration of GFSE
has an average # of standard deviations of less than 1, meaning it considered similar to
the control. This means the growth rate of the P. zopfii subjected to the highest level of
GFSE is not different from the growth rate of the P. zopfii control. In fact, if you look at
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slopes all of the treatments, they are all within 1 standard deviation of the average of the
controls. Thus, it is safe to say, the growth rate of the P. zopfii in all the treatment tubes
was equivalent to that of the growth rate in the positive control 47% PIM + DW, and thus
the GFSE concentrations had no effect on the growth rate of the P. zopfii.
Experiment 3 was run because we realized we may have rendered the
antimicrobial compounds in the GFSE inactive when we autoclaved it in Experiment 2.
We autoclaved the GFSE because we did not know if it was sterile or not, and did not
want other organisms to grow in the PIM broth and effect the spectroscopy results.
However, we neglected to realize that by heating the GFSE solutions to 212oF, we were
possibly inactivating compounds within the GFSE. Thus, while there was technically
GFSE in with the P. zopfii, there is a possibility the GFSE was no longer capable of
killing the P. zopfii. Instead of autoclaving the GFSE solutions, we decided to redo the
experiment, and to run the GFSE dilutions through a 0.2micron filter. The filter would
“catch” any bacteria, and thus sterilize the GFSE without denaturing any compounds
within it. However, it was simply a hypothesis that we rendered the GFSE ineffective by
autoclaving it.
Realistically, there is a chance the GFSE compounds were still intact during
Experiment 2, and we realized that we did not have a control to prove whether the GFSE
was rendered ineffective. However, it was noted that the color of the GFSE after being
filtered was much lighter than the autoclaved GFSE. We are unsure of whether this is
because autoclaving the GFSE darkened the color (thus suggesting the compounds may
have been affected by autoclaving), or if perhaps the filters were catching enough of the
GFSE to cause a reduction in color. The filters did indeed prevent a significant amount of
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GFSE from passing through, as indicated by the difficulty in pushing down the plunger of
the syringe, and by the filter turning slightly reddish in color. Whether the filters were
catching the “active ingredients” in the GFSE is unknown, thus the concentrations of
GFSE in Experiment 3are not guaranteed accurate due to the filtering process. However,
the colors indicated there was indeed more GFSE in the highest concentration treatment,
and we can say the growth rate of the P. zopfii did not appear different from that of the
treatment in Experiment 3.
Overall, the data does not support our hypothesis that GFSE inhibits the growth of
P. zopfii. There are three main reasons why we may have obtained the data we did.
Firstly, perhaps GFSE does not have any antimicrobial properties at all. Many researchers
have suggested that it is the chemicals used to extract the GFSE that can cause it to be
antimicrobial against other bacteria and fungi [13], not the actual compounds found in the
GFSE. To determine this we should have run the experiment on bacteria that are easier to
kill than the algae P. zopfii, such as E. coli. If we had done this during Experiment 2 with
the autoclaved GFSE, and the GFSE inhibited E. coli growth, then we would have known
the GFSE does have some form of antimicrobial properties. We also would have known
the GFSE was still activated after it was autoclaved and thus would not have had to run
Experiment 3.
If the GFSE was effective against the E. coli and not the P. zopfii, we would know
that the concentrations of GFSE used were simply ineffective against the wall or some
other aspect of the P. zopfii cells. This would be the second reason why we obtained the
results we did.
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Another possibility is that perhaps we were not using a high enough concentration
of GFSE to effectively kill the P. zopfii. We attempted to use the highest concentration
that would fully dissolve into the DW. However, we also could have used a different
solvent to increase the concentration of the GFSE. This tactic may have resulted in a
solution that is not a viable treatment for intramammary infusion for dairy cattle mastitis,
because the treatment would not disperse well through the water (milk) in the cow’s
udder. Thus, we did not explore this experimental route. Alternatively, we could have
altered the pH of the solution to increase the amount of GFSE that would dissolve in
solution. Because the pH of the GFSE solution was between 4-7, that means the GFSE is
slightly acidic. Had we added a base to the DW, we could have increased the amount of
GFSE that could be dissolved in the DW and thus increased the concentration. However,
we would have wanted to keep the pH between 5 and 7, because this is the optimum pH
for P. zopfii growth.
Future research would require ensuring the GFSE does indeed have some
antimicrobial properties, by testing it against some bacteria such as E. coli. If the GFSE is
found to possess antimicrobial properties, we could attempt to increase the GFSE
concentration using buffers. Once the highest concentration is reached and tested against
the P. zopfii, we could attempt to use a different solvent to increase the concentration
even more to sufficiently support or disprove the if GFSE is effective against Prototheca
growth. As mentioned, the only problem with this is the solvent may not be sufficient for
intramammary injection.
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DATA TABLES
Experiment 2
Table 3.

Absorbance (A) of GFSE treatments

Treatments
A1
A2
B1
B2
C1
C2
D1
D2
E1
E2
F1
F2

A at 0 hours
0.06
0.07
0.07
0.1
0.08
0.08
0.08
0.1
0.11
0.19
0.08
0.1

A at 24 hours
0.12
0.15
0.13
0.17
0.13
0.15
0.12
0.17
0.19
0.26
0.16
0.21

A at 48 hours
0.18
0.21
0.17
0.22
0.17
0.2
0.17
0.23
0.23
0.31
0.21
0.26

A at 72 hours
0.2
0.24
0.21
0.25
0.21
0.24
0.22
0.28
0.27
0.36
0.25
0.32

The spectrophotometer was blanked with GP1-GP6 for each corresponding dilution of
GFSE (A1,A2-F1,F2). The spectrophotometer was set to 570nm. Based on the continual
decrease of T, it can be concluded that the prototheca continued to grow, and thus the
different concentrations of GFSE had no effect on protothecal growth.

Table 4.

Absorbance of 47% PIM

47% PIM
Ia
Ib
Ic
Id
Ie
If

A at 0 hours
0.34
0.33
0.335
0.33
0.34
0.33

A at 24 hours
0.35
0.37
0.4
0.42
0.43
0.39

A at 48 hours
0.44
0.45
0.46
0.45
0.45
0.45

A at 72 hours
0.48
0.5
0.51
0.54
0.55
0.5

The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the
continual increase of A, it can be concluded that the prototheca continued to grow, and
thus was a successful positive control.
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Table 5.

Absorbance of 47% PIM + Distilled Water

47% PIM + DW
X1
X2
X3
X4
X5
X6

A at 0 hours
0.15
0.15
0.15
0.15
0.15
0.15

A at 24 hours
0.2
0.2
0.21
0.21
0.2
0.2

A at 48 hours
0.25
0.25
0.27
0.26
0.25
0.25

A at 72 hours
0.3
0.31
0.32
0.32
0.31
0.31

A at 24 hours
N/A
N/A
N/A
N/A
N/A
N/A

A at 48 hours
1
1
1
1
1
1

A at 72 hours
N/A
N/A
N/A
N/A
N/A
N/A

The spectrophotometer was blanked with 3mL of PIM broth and 3mL of distilled water
and was set to 570nm. Based on the continual increase of A, it can be concluded that the
prototheca continued to grow, and thus was a successful positive control.

Table 6.

Absorbance of PIM ONLY

PIM ONLY
Pa
Pb
Pc
Pd
Pe
Pf

A at 0 hours
1
1
1
1
1
1

The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the
consistent absorbency readings, it can be inferred that: there was no growth within the
PIM broth, and thus was a successful positive control.
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Experiment 3

Table 7.

Absorbance (A) of GFSE treatments

Treatments
A1
A2
B1
B2
C1
C2
D1
D2
E1
E2
F1
F2

A at 0 hours
0.17
0.17
0.16
0.16
0.16
0.17
0.17
0.17
0.16
0.17
0.16
0.16

A at 24 hours
0.3
0.3
0.3
0.3
0.32
0.32
0.31
0.32
0.31
0.33
0.31
0.32

A at 48 hours
0.38
0.38
0.35
0.36
0.4
0.38
0.37
0.37
0.37
0.4
0.28
0.39

A at 72 hours
0.43
0.43
0.41
0.42
0.46
0.44
0.43
0.43
0.42
0.46
0.43
0.44

The spectrophotometer was blanked with GP1-GP6 for each corresponding dilution of
GFSE (A1,A2-F1,F2). The spectrophotometer was set to 570nm. Based on the continual
decrease of T, it can be concluded that the prototheca continued to grow, and thus the
different concentrations of GFSE had no effect on protothecal growth.

Table 8.

Absorbance of 47% PIM

47% PIM
Ia
Ib
Ic
Id
Ie
If

A at 0 hours
0.33
0.33
0.33
0.33
0.33
0.33

A at 24 hours
0.5
0.5
0.5
0.5
0.5
0.5

A at 48 hours
0.6
0.61
0.59
0.56
0.58
0.56

A at 72 hours
0.66
0.64
0.64
0.62
0.64
0.64

The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the
continual increase of A, it can be concluded that the prototheca continued to grow, and
thus was a successful positive control.
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Table 9. Absorbance of 47% PIM + Distilled Water
47% PIM + DW
X1
X2
X3
X4
X5
X6

A at 0 hours
0.16
0.16
0.15
0.15
0.16
0.16

A at 24 hours
0.28
0.28
0.27
0.28
0.28
0.27

A at 48 hours
0.35
0.35
0.33
0.34
0.34
0.33

A at 72 hours
0.4
0.4
0.38
0.4
0.4
0.37

A at 48 hours
N/A
N/A
N/A
N/A
N/A
N/A

A at 72 hours
1
1
1
1
1
1

The spectrophotometer was blanked with 3mL of PIM broth and 3mL of distilled water
and was set to 570nm. Based on the continual increase of A, it can be concluded that the
prototheca continued to grow, and thus was a successful positive control.

Table 10.

Absorbance of PIM ONLY

PIM ONLY
Pa
Pb
Pc
Pd
Pe
Pf

A at 0 hours
1
1
1
1
1
1

A at 24 hours
N/A
N/A
N/A
N/A
N/A
N/A

The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the
consistent absorbency readings, it can be inferred that: there was no growth within the
PIM broth, and thus was a successful positive control.
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APPENDIX 2
ATCC medium: 1371 Prototheca isolation medium (PIM)
Potassium hydrogen phthalate......10.0 g
NaOH...............................0.9 g
MgSO4 ..............................0.1 g
KH2PO4 .............................0.2 g
NH4Cl ..............................0.3 g
Glucose...........................10.0 g
Thiamine . HCl.....................0.001 g
Agar..............................20.0 g
5-Fluorocytosine*..................0.25 g
Distilled water to.................1.0 L
Adjust pH to 5.1 +/- 0.1 and autoclave at 121C for 15-20
minutes.
*May be left out of medium for routine maintenance.
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